Supplementary Data for DOAC vs. LMWH Safety Study in European Cancer Patients

2013 to 2020 data from Sweden, Norway, Finland, the UK, and Germany supports a peer-reviewed comparative safety study. The dataset contains supplementary materials for an article published in the Journal of Comparative Effectiveness Research. It includes ICD-10 codes, cancer risk types, power calculations, and baseline characteristics for over 30,000 patients treated with direct oral anticoagulants or low-molecular-weight heparin.

Use Cases

• Replicate statistical analyses based on the provided inverse probability of treatment weighting (IPTW) methodology.
• Compare baseline patient characteristics across five European healthcare systems.
• Assess power calculations for bleeding and recurrent VTE outcomes.
• Validate ICD-10 code sets for identifying venous thromboembolism in clinical data.

Strengths

• Data spans 2013 to 2020 from five European countries.
• Includes results for over 30,000 patients after inverse probability of treatment weighting.
• Peer-reviewed supplementary materials for a published journal article.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The 151.6 KB file size suggests a limited scope, likely containing summary tables rather than patient-level records.

Provenance

Source

figshare

Collection Method

Observational cohort study using national patient and prescription registers from Sweden, Norway, Finland, the UK, and Germany.

Time Range

2013 to 2020

Freshness

Last updated 2026-05-01 10:49:20; freshness should be verified.

Geography

Sweden, Norway, Finland, United Kingdom, Germany